secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001824293-25-000063
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio increases ATM offering capacity by up to $1.67M, on top of $3.6M already sold
--------------------------------------------------------------------------------

- Prospectus supplement filed to increase ATM issuance by up to $1.67M, on top of $3.6M previously sold.
- Shares sold to date total $3,604,683; new maximum of $1,670,956 does not include prior sales.
- ATM sales agreement with H.C. Wainwright dated May 20, 2024; offering of common stock provides incremental equity financing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000063/0001824293-25-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429325000063/val-20250505.htm
  HTML page:      https://secwatch.observer/filing/0001824293-25-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer